150 related articles for article (PubMed ID: 25201939)
21. Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion.
Moynihan CK; Burke PA; Evans SA; O'Donoghue AC; Sullivan HW
J Am Board Fam Med; 2018; 31(4):645-649. PubMed ID: 29986991
[TBL] [Abstract][Full Text] [Related]
22. [Off-label prescriptions in public psychiatric hospital practice].
Andréoli L; Gaudoneix M; Beauverie P; de Beaurepaire R
Therapie; 2013; 68(6):347-59. PubMed ID: 24246118
[TBL] [Abstract][Full Text] [Related]
23. Initiating inhaled steroid treatment for children with asthma in the emergency room: current reported prescribing rates and frequently cited barriers.
Andrews AL; Teufel RJ; Basco WT
Pediatr Emerg Care; 2013 Sep; 29(9):957-62. PubMed ID: 23974712
[TBL] [Abstract][Full Text] [Related]
24. Off-label prescribing patterns of antidepressants in children and adolescents.
Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
[TBL] [Abstract][Full Text] [Related]
25. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
Wang B; Canestaro WJ; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
[TBL] [Abstract][Full Text] [Related]
26. Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.
Paschall S; Kaunitz AM
Contraception; 2008 Nov; 78(5):370-6. PubMed ID: 18929733
[TBL] [Abstract][Full Text] [Related]
27. Primary care physicians and elder abuse: current attitudes and practices.
Wagenaar DB; Rosenbaum R; Page C; Herman S
J Am Osteopath Assoc; 2010 Dec; 110(12):703-11. PubMed ID: 21178151
[TBL] [Abstract][Full Text] [Related]
28. Lipid-lowering pharmacotherapy in Central and Eastern European countries in cardiovascular prevention: self-reported prescription patterns of primary care physicians.
Tomasik T; Windak A; Seifert B; Kersnik J; Kijowska V; Dubas K
J Cardiovasc Pharmacol Ther; 2013 May; 18(3):234-42. PubMed ID: 23277158
[TBL] [Abstract][Full Text] [Related]
29. Perceptions and practices regarding herbal medicine prescriptions among physicians in Greater Beirut.
Ala Aeddine N; Khayat M; Alawieh H; Adibilly S; Adib S
J Med Liban; 2014; 62(3):130-6. PubMed ID: 25306792
[TBL] [Abstract][Full Text] [Related]
30. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
31. Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice.
Shea MB; Stewart M; Van Dyke H; Ostermann L; Allen J; Sigal E
Ther Innov Regul Sci; 2018 Nov; 52(6):771-777. PubMed ID: 29714570
[TBL] [Abstract][Full Text] [Related]
32. The prescription of opioid analgesics to terminal cancer patients: impact of physicians' general attitudes and contextual factors.
Peretti-Watel P; Bendiane MK; Obadia Y; Favre R; Lapiana JM; Moatti JP;
Palliat Support Care; 2003 Dec; 1(4):345-52. PubMed ID: 16594224
[TBL] [Abstract][Full Text] [Related]
33. Awareness, perceptions and knowledge of recommended adult vaccines among a nationwide sample of adult primary care providers.
Tan TQ; Bhattacharya L; Gerbie MV
J Reprod Med; 2011; 56(7-8):301-7. PubMed ID: 21838159
[TBL] [Abstract][Full Text] [Related]
34. Direct observation of requests for clinical services in office practice: what do patients want and do they get it?
Kravitz RL; Bell RA; Azari R; Kelly-Reif S; Krupat E; Thom DH
Arch Intern Med; 2003 Jul; 163(14):1673-81. PubMed ID: 12885682
[TBL] [Abstract][Full Text] [Related]
35. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use.
Meadows WA; Hollowell BD
Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389
[TBL] [Abstract][Full Text] [Related]
36. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
[TBL] [Abstract][Full Text] [Related]
37. Prescribing trends by nurse practitioners and physician assistants in the United States.
Cipher DJ; Hooker RS; Guerra P
J Am Acad Nurse Pract; 2006 Jun; 18(6):291-6. PubMed ID: 16719848
[TBL] [Abstract][Full Text] [Related]
38. International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United States.
Song YK; Han N; Burckart GJ; Oh JM
Clin Pharmacol Ther; 2020 Mar; 107(3):530-540. PubMed ID: 31544241
[TBL] [Abstract][Full Text] [Related]
39. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
40. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
